Testing therapies less effective than the best current standard: Ethical beliefs in an international sample of researchers

American Journal of Bioethics

Volumn 3, Issue 2, 2003, Pages W28-W33

  Kent, David M ^a   Bennish, Michael L ^b   Cash, Richard A ^c   Rabin, Tracy L ^d  

^a TUFTS MEDICAL CENTER   (United States)

^b AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012504868     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1162/152651603322874898     Document Type: Article

References (15)

1. Angell, M. 1997. The ethics of clinical research in the Third World. New England Journal of Medicine 337:847-9.
2. Annas, G. J., and M. A. Grodin. 1998. Human rights and maternal-fetal HIV transmission prevention trials in Africa. American Journal of Public Health 88(4): 560-3.
3. Connor, E. M., R. S. Sperling, R. Gelber et al. 1994. Reduction of maternalinfant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine 331:1173-80.
4. Freedman, B. 1987. Equipoise and the ethics of clinical research. New England Journal of Medicine 317:141-5.
5. Guay, L.A., P. Musoke, T. Fleming et al. 1999. Intrapartum and neonatal single- dose nevirapine compared with zidovudine for prevention of mother-tochild transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial. Lancet 354:795-802.
6. Levine, R. J. 1999. The need to revise the Declaration of Helsinki. New England Journal of Medicine 341:531-4.
7. Lurie, P., and S. M. Wolfe. 1997. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. New England Journal of Medicine 337:853-6.
8. Lurie, P., and S. M. Wolfe 1998. Ethics and international research. Comparison of short and long zidovudine regimens is appropriate. British Medical Journal 316:626.
9. Lurie, P., and S. M. Wolfe. 1999. HIVNET nevirapine trials. Lancet 354:1816-7.
10. Shaffer, N., R. Chuachoowong, P.A. Mock et al. 1999. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 353:773-80.
11. Varmus, H., and D. Satcher. 1997. Ethical complexities of conducting research in developing countries. New England Journal of Medicine 337:1003-5.
12. Wiktor, S.Z., E. Ekpini, J. M. Karon et al. 1999. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d’Ivoire: A randomized trial. Lancet 353:781-5.
13. Wilkinson, D., S. S. Karim, and H. M. Coovadia. 1999. Short course antiretroviral regimens to reduce maternal transmission of HIV. British Medical Journal 318:479-80.
14. World Medical Association. 1996. Declaration of Helsinki. Rev. ed. Somerset West, Republic of South Africa 48th WMA General Assembly, October.
15. World Medical Association. 2000. Declaration of Helsinki, as amended at the 52nd WMA General Assembly, Edinburgh, Scotland, October. Available from: www.wma.net/e/policy/17-c_e.html